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Anti-malarial activities of two actinomycete isolates from sabah soil involved 
inhibition of glycogen synthase kinase 3ß 
Abstract 
Exploiting natural resources for bioactive compounds is an attractive drug 
discovery strategy in search for new anti-malarial drugs with novel modes of 
action. Initial screening efforts in our laboratory revealed two preparations of soil-
derived actinomycetes (H11809 and FH025) with potent anti-malarial activities. 
Both crude extracts showed glycogen synthase kinase 3β (GSK3β)-inhibitory 
activities in a yeast-based kinase assay. We have previously shown that the 
GSK3 inhibitor, lithium chloride (LiCl), was able to suppress parasitaemia 
development in a rodent model of malarial infection. The present study aims to 
evaluate whether anti-malarial activities of H11809 and FH025 involve the 
inhibition of GSK3β. The acetone crude extracts of H11809 and FH025 each 
exerted strong inhibition on the growth of Plasmodium falciparum 3D7 in vitro 
with 50% inhibitory concentration (IC50) values of 0.57 ± 0.09 and 1.28 ± 0.11 
µg/mL, respectively. The tested extracts exhibited Selectivity Index (SI) values 
exceeding 10 for the 3D7 strain. Both H11809 and FH025 showed dosage-
dependent chemo-suppressive activities in vivo and improved animal survivability 
compared to non-treated infected mice. Western analysis revealed increased 
phosphorylation of serine (Ser 9) GSK3β (by 6.79 to 6.83-fold) in liver samples 
from infected mice treated with H11809 or FH025 compared to samples from 
non-infected or non-treated infected mice. A compound already identified in 
H11809 (data not shown), dibutyl phthalate (DBP) showed active anti-plasmodial 
activity against 3D7 (IC50 4.87 ± 1.26 µg/mL which is equivalent to 17.50 µM) 
and good chemo-suppressive activity in vivo (60.80% chemo-suppression at 300 
mg/kg body weight [bw] dosage). DBP administration also resulted in increased 
phosphorylation of Ser 9 GSK3β compared to controls. Findings from the present 
study demonstrate that the potent anti-malarial activities of H11809 and FH025 
were mediated via inhibition of host GSK3β. In addition, our study suggests that 
DBP is in part the bioactive component contributing to the antimalarial activity 
displayed by H11809 acting through the inhibition of GSK3β. 
